Not applicableLooking for participantsNCT05102747
What this trial is testing
Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.
Who this might be right for
Brain MetastasisOligoprogression
Centre Francois Baclesse 504